Literature DB >> 18212182

Severe acute hyperammonemia after brief exposure to valproate.

Aubrey L Eubanks1, Betzabel Aguirre, James A Bourgeois.   

Abstract

The authors describe a case of acute hyperammonemia after the addition of valproate to the medication regimen of a patient on multiple psychotropic medications. The patient presented with acute mental-status changes consistent with delirium. With prompt intervention and supportive care, her delirium quickly cleared.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212182     DOI: 10.1176/appi.psy.49.1.82

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  5 in total

Review 1.  Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.

Authors:  Estee Chan; Fiona McQueen
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

2.  Valproic Acid-Induced Hyperammonemic Encephalopathy as a Cause of Neurologic Deterioration after Unruptured Aneurysm Surgery.

Authors:  Sangkook Lee; Jinhwan Cheong; Choonghyun Kim; Jae Min Kim
Journal:  J Korean Neurosurg Soc       Date:  2015-08-28

3.  Pronounced reversible hyperammonemic encephalopathy associated with combined valproate-topiramate therapy in a 7-year-old girl.

Authors:  Sebastian Weise; Steffen Syrbe; Matthias Preuss; Astrid Bertsche; Andreas Merkenschlager; Matthias K Bernhard
Journal:  Springerplus       Date:  2015-06-17

Review 4.  Hyperammonemic coma after craniotomy: Hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: Case report and literature review.

Authors:  Xiaopeng Guo; Junji Wei; Lu Gao; Bing Xing; Zhiqin Xu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review.

Authors:  Lauren M Brown; Nicole Cupples; Troy A Moore
Journal:  Ment Health Clin       Date:  2018-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.